Paul J. Clancy
2009
In 2009, Paul J. Clancy earned a total compensation of $2.4M as EVP and Chief Financial Officer at Biogen, a 38% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $6,456 |
|---|---|
| Non-Equity Incentive Plan | $279,840 |
| Option Awards | $475,884 |
| Salary | $524,231 |
| Stock Awards | $999,951 |
| Other | $101,039 |
| Total | $2,387,401 |
Clancy received $1M in stock awards, accounting for 42% of the total pay in 2009.
Clancy also received $6.5K of change in pension value and nonqualified deferred compensation earnings, $279.8K in non-equity incentive plan, $475.9K in option awards, $524.2K in salary and $101K in other compensation.
Rankings
In 2009, Paul J. Clancy's compensation ranked 1,970th out of 9,885 executives tracked by ExecPay. In other words, Clancy earned more than 80.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,970 out of 9,885 | 80th |
Division Manufacturing | 691 out of 3,690 | 81st |
Major group Chemicals And Allied Products | 131 out of 871 | 85th |
Industry group Drugs | 81 out of 643 | 87th |
Industry Biological Products, Except Diagnostic Substances | 12 out of 138 | 91st |
Source: SEC filing on April 27, 2012.
Clancy's colleagues
We found five more compensation records of executives who worked with Paul J. Clancy at Biogen in 2009.